Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamic-GUIDEd Management of Heart Failure

NCT03387813 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03387813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03387813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamic-GUIDEd Management of Heart Failure
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2018
Completion date
May 17, 2023
Enrollment
2,358 (actual)
Sites
129

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure nyha class ii, heart failure nyha class iii, heart failure nyha class iv, heart failure with normal ejection fraction, heart failure with reduced ejection fraction, heart failure, diastolic, heart failure, systolic, heart failure; with decompensation, heart failure，congestive